{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:03Z","timestamp":1786980243163,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00464-019-07205-y","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:18:06Z","timestamp":1571332686000},"page":"4347-4357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study"],"prefix":"10.1007","volume":"34","author":[{"given":"Eliza R. C.","family":"Hagens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah T.","family":"K\u00fcnzli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"van Rijswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybren L.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Clinton D.","family":"Mijnals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas L. A. M.","family":"Weusten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Debby","family":"Geijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W. M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne S.","family":"Gisbertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"7205_CR1","unstructured":"(2017) DICA_Jaarrapportage_2017_-_Registraties"},{"key":"7205_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/SLA.0b013e318188c474","volume":"248","author":"CG Peyre","year":"2008","unstructured":"Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, H\u00f6lscher A, Lerut T, Law S, Rice TW, Ruol A, Van Lanschot JJB, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549\u2013554. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e318188c474","journal-title":"Ann Surg"},{"key":"7205_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/SLA.0b013e31815aaadf","volume":"247","author":"C Mariette","year":"2008","unstructured":"Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365\u2013371. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e31815aaadf","journal-title":"Ann Surg"},{"key":"7205_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.07.039","author":"N Rizk","year":"2006","unstructured":"Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V (2006) The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. \nhttps:\/\/doi.org\/10.1016\/j.jtcvs.2006.07.039","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7205_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1245\/s10434-008-0169-7","volume":"16","author":"AM Koenig","year":"2008","unstructured":"Koenig AM, Prenzel KL, Bogoevski D, Yekebas EF, Bubenheim M, Faithova L, Vashist YK, Gawad KA, Baldus SE, Pantel K, Schneider PM, H\u00f6lscher AH, Izbicki JR (2008) Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol 16:454\u2013462. \nhttps:\/\/doi.org\/10.1245\/s10434-008-0169-7","journal-title":"Ann Surg Oncol"},{"key":"7205_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/SLA.0b013e31817bbe59","volume":"248","author":"NK Altorki","year":"2008","unstructured":"Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248:221\u2013226. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e31817bbe59","journal-title":"Ann Surg"},{"key":"7205_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/cncr.23309","volume":"112","author":"AJ Greenstein","year":"2008","unstructured":"Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP (2008) Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112:1239\u20131246. \nhttps:\/\/doi.org\/10.1002\/cncr.23309","journal-title":"Cancer"},{"key":"7205_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jso.23965","volume":"112","author":"H Miyata","year":"2015","unstructured":"Miyata H, Yamasaki M, Makino T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2015) Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol 112:60\u201365. \nhttps:\/\/doi.org\/10.1002\/jso.23965","journal-title":"J Surg Oncol"},{"key":"7205_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ijrobp.2010.08.037","volume":"82","author":"J Chen","year":"2012","unstructured":"Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z (2012) Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:475\u2013482. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2010.08.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7205_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, van der Gaast A, van Lanschot JJB, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rutten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MCCM (2014) Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol 32:385\u2013391. \nhttps:\/\/doi.org\/10.1200\/JCO.2013.51.2186","journal-title":"J Clin Oncol"},{"key":"7205_CR11","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1245\/s10434-011-1753-9","volume":"18","author":"C Castoro","year":"2011","unstructured":"Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E (2011) Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol 18:3743\u20133754. \nhttps:\/\/doi.org\/10.1245\/s10434-011-1753-9","journal-title":"Ann Surg Oncol"},{"key":"7205_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00268-013-2236-x","volume":"38","author":"AK Talsma","year":"2014","unstructured":"Talsma AK, Ong C-AJ, Liu X, van Hagen P, Van Lanschot JJB, Tilanus HW, Hardwick RH, Carroll NR, Spaander MCW, Fitzgerald RC, Wijnhoven BPL (2014) Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival. World J Surg 38:106\u2013113. \nhttps:\/\/doi.org\/10.1007\/s00268-013-2236-x","journal-title":"World J Surg"},{"key":"7205_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000001737","author":"AW Phiillips","year":"2016","unstructured":"Phiillips AW, Lagarde SM, Navidi M, Disep B, Griffin SM (2016) Impact of extent of lymphadenectomy on survival, post neoadjuvant chemotherapy and trans-thoracic esophagectomy. Ann Surg. \nhttps:\/\/doi.org\/10.1097\/sla.0000000000001737","journal-title":"Ann Surg"},{"key":"7205_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/SLA.0000000000001594","volume":"265","author":"TW Rice","year":"2017","unstructured":"Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut T, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH (2017) Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg 265:122\u2013129. \nhttps:\/\/doi.org\/10.1097\/SLA.0000000000001594","journal-title":"Ann Surg"},{"key":"7205_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002824","author":"E Visser","year":"2018","unstructured":"Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R (2018) Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg. \nhttps:\/\/doi.org\/10.1097\/SLA.0000000000002824","journal-title":"Ann Surg"},{"key":"7205_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1010-7940(99)00122-0","volume":"15","author":"C Van De Ven","year":"1999","unstructured":"Van De Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T (1999) Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardio-thoracic Surg 15:769\u2013773. \nhttps:\/\/doi.org\/10.1016\/S1010-7940(99)00122-0","journal-title":"Eur J Cardio-thoracic Surg"},{"key":"7205_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF01427033","volume":"24","author":"S Sharma","year":"1994","unstructured":"Sharma S, Fujita H, Yamana H, Kakegawa T (1994) Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 24:410\u2013414","journal-title":"Surg Today"},{"key":"7205_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806\u2013808. \nhttps:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"7205_CR19","unstructured":"Maureen M. de Boer, Bas Wijnhoven, Ate van der Gaast, Tom Rozema, Grard Nieuwenhuijzen GJBH en PDS (2011) Herziene richtlijn \u2018Oesofaguscarcinoom.\u2019 Ned Tijdschr Geneeskd 155:"},{"key":"7205_CR20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/nejmoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, Henegouwen MI, Wijnhoven BPL, Richel DJ, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, ten Kate FJW, Creemers G-J, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074\u20132084. \nhttps:\/\/doi.org\/10.1056\/nejmoa1112088","journal-title":"N Engl J Med"},{"key":"7205_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, ten Kate FJW, Creemers G-JM, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090\u20131098. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(15)00040-6","journal-title":"Lancet Oncol"},{"key":"7205_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2482-11-2","volume":"11","author":"SS Biere","year":"2011","unstructured":"Biere SS, Maas KW, Bonavina L, Garcia JR, Van Berge Henegouwen MI, Rosman C, Sosef MN, De Lange ES, Bonjer HJ, Cuesta MA, Van Der Peet DL (2011) Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surg 11:1\u20137. \nhttps:\/\/doi.org\/10.1186\/1471-2482-11-2","journal-title":"BMC Surg"},{"key":"7205_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","volume":"379","author":"SS Biere","year":"2012","unstructured":"Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887\u20131892. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(12)60516-9","journal-title":"Lancet"},{"key":"7205_CR24","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","volume":"17","author":"TW Rice","year":"2010","unstructured":"Rice TW, Blackstone EH, Rusch VW (2010) Editorial: 7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721\u20131724. \nhttps:\/\/doi.org\/10.1245\/s10434-010-1024-1","journal-title":"Ann Surg Oncol"},{"key":"7205_CR25","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR25>3.0.CO;2-C","volume":"73","author":"A-M Mandard","year":"1994","unstructured":"Mandard A-M, Dalibard F, Mandard J-C, Marnay J, Henry-Amar M, Petiot J-F, Roussel A, Jacob J-H, Segol P, Samama G, Ollivier J-M, Bonvalot S, Gignoux M (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680\u20132686. \nhttps:\/\/doi.org\/10.1002\/1097-0142(19940601)73:11%3c2680:AID-CNCR25%3e3.0.CO;2-C","journal-title":"Cancer"},{"key":"7205_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/JTO.0b013e31827e1f6d","volume":"8","author":"J Cheng","year":"2013","unstructured":"Cheng J, Kong L, Huang W, Li B, Li H, Wang Z, Zhang J, Zhou T, Sun H (2013) Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases. J Thorac Oncol 8:359\u2013365. \nhttps:\/\/doi.org\/10.1097\/JTO.0b013e31827e1f6d","journal-title":"J Thorac Oncol"},{"key":"7205_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ejcts\/ezt607","volume":"46","author":"S Shin","year":"2014","unstructured":"Shin S, Kim HK, Choi YS, Kim K, Shim YM (2014) Clinical stage T1-T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis. Eur J Cardiothorac Surg 46:274\u2013279. \nhttps:\/\/doi.org\/10.1093\/ejcts\/ezt607\n\ndiscussion 279","journal-title":"Eur J Cardiothorac Surg"},{"key":"7205_CR28","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.athoracsur.2015.02.112","volume":"99","author":"A Dubecz","year":"2015","unstructured":"Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ (2015) Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer. Ann Thorac Surg 99:1879\u20131885. \nhttps:\/\/doi.org\/10.1016\/j.athoracsur.2015.02.112\n\ndiscussion 1886","journal-title":"Ann Thorac Surg"},{"key":"7205_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ejso.2018.11.011","volume":"45","author":"B Schurink","year":"2019","unstructured":"Schurink B, Seesing MFJ, Goense L, Mook S, Brosens LAA, Mohammad NH, Ruurda JP, Roeling TAP, Bleys RLAW, van Hillegersberg R (2019) ypT0N+\u2009status in oesophageal cancer patients: location of residual metastatic lymph nodes with regard to the neoadjuvant radiation field. Eur J Surg Oncol 45:454\u2013459. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2018.11.011","journal-title":"Eur J Surg Oncol"},{"key":"7205_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00000658-200008000-00013","volume":"232","author":"N Ando","year":"2000","unstructured":"Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225\u2013232","journal-title":"Ann Surg"},{"key":"7205_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejso.2012.01.007","volume":"38","author":"KL Prenzel","year":"2012","unstructured":"Prenzel KL, H\u00f6lscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E (2012) Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol 38:314\u2013318. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2012.01.007","journal-title":"Eur J Surg Oncol"},{"key":"7205_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1442-2050.2010.01086.x","volume":"24","author":"Y Tachimori","year":"2011","unstructured":"Tachimori Y, Nagai Y, Kanamori N, Hokamura N, Igaki H (2011) Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus 24:33\u201338. \nhttps:\/\/doi.org\/10.1111\/j.1442-2050.2010.01086.x","journal-title":"Dis Esophagus"},{"key":"7205_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00276-007-0257-6","volume":"29","author":"H Saito","year":"2007","unstructured":"Saito H, Sato T, Miyazaki M (2007) Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat 29:531\u2013542. \nhttps:\/\/doi.org\/10.1007\/s00276-007-0257-6","journal-title":"Surg Radiol Anat"},{"key":"7205_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0022-5223(03)00036-9","volume":"125","author":"K Kuge","year":"2003","unstructured":"Kuge K, Murakami G, Mizobuchi S, Hata Y, Aikou T, Sasaguri S (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343\u20131349. \nhttps:\/\/doi.org\/10.1016\/S0022-5223(03)00036-9","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7205_CR35","first-page":"247","volume":"45","author":"HA Cense","year":"2004","unstructured":"Cense HA, Sloof GW, Klaase JM, Bergman JJ, van Hemert FJ, Fockens P, van Lanschot JJB (2004) Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. J Nucl Med 45:247\u2013252","journal-title":"J Nucl Med"},{"key":"7205_CR36","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.athoracsur.2010.07.008","volume":"90","author":"KL Prenzel","year":"2010","unstructured":"Prenzel KL, Bollschweiler E, Schroder W, Monig SP, Drebber U, Vallboehmer D, Holscher AH (2010) Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 90:1662\u20131667. \nhttps:\/\/doi.org\/10.1016\/j.athoracsur.2010.07.008","journal-title":"Ann Thorac Surg"},{"key":"7205_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6584","author":"CJ Peters","year":"2009","unstructured":"Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC (2009) Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg. \nhttps:\/\/doi.org\/10.1002\/bjs.6584","journal-title":"Br J Surg"},{"key":"7205_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/bjs.5832","volume":"94","author":"SM Lagarde","year":"2007","unstructured":"Lagarde SM, Reitsma JB, De Castro SMM, Ten Kate FJW, Busch ORC, Van Lanschot JJB (2007) Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg 94:1361\u20131368. \nhttps:\/\/doi.org\/10.1002\/bjs.5832","journal-title":"Br J Surg"},{"key":"7205_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/SLA.0b013e318190a0a2","volume":"248","author":"SM Lagarde","year":"2008","unstructured":"Lagarde SM, Reitsma JB, Ten Kate FJW, Busch ORC, Obertop H, Zwinderman AH, Moons J, Van Lanschot JJB, Lerut T (2008) Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction. Ann Surg 248:1006\u20131012. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e318190a0a2","journal-title":"Ann Surg"},{"key":"7205_CR40","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.21037\/jtd.2018.06.51","volume":"10","author":"W Shen","year":"2018","unstructured":"Shen W, Shen Y, Tan L, Jin C, Xi Y (2018) A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma. J Thorac Dis 10:4178\u20134185. \nhttps:\/\/doi.org\/10.21037\/jtd.2018.06.51","journal-title":"J Thorac Dis"},{"key":"7205_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suronc.2017.11.002","volume":"27","author":"X-F Duan","year":"2018","unstructured":"Duan X-F, Tang P, Shang X-B, Jiang H-J, Yu Z-T (2018) The prevalence of lymph node metastasis for pathological T1 esophageal cancer: a retrospective study of 143 cases. Surg Oncol 27:1\u20136. \nhttps:\/\/doi.org\/10.1016\/j.suronc.2017.11.002","journal-title":"Surg Oncol"},{"key":"7205_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.radonc.2015.10.005","volume":"117","author":"P Jin","year":"2015","unstructured":"Jin P, van der Horst A, de Jong R, van Hooft JE, Kamphuis M, van Wieringen N, Machiels M, Bel A, Hulshof MCCM, Alderliesten T (2015) Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer. Radiother Oncol 117:412\u2013418. \nhttps:\/\/doi.org\/10.1016\/j.radonc.2015.10.005","journal-title":"Radiother Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-07205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-019-07205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-07205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T19:12:09Z","timestamp":1602789129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-019-07205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["7205"],"URL":"https:\/\/doi.org\/10.1007\/s00464-019-07205-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs Hagens, K\u00fcnzli, van Rijswijk, Meijer, Mijnals, Geijsen, and Gisbertz have no conflicts of interest of financial ties to disclose. van Berge Henegouwen has served as consultant for Medtronic and has received unrestricted research funding from Olympus and Stryker. Hanneke W. M. van Laarhoven has served as a consultant for BMS, Celgene, Lilly, and Nordic and has received unrestricted research funding from Bayer, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, and Roche. Bas Weusten received research support for IRB approved studies from GI Solutions Covidien, Erbe, and C2 Therapeutics. He received a honorarium consultancy speakers fee of Boston Scientific and C2Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}